News
Keep Up with GlycoMira
Press Releases
GlycoMira receives $2.8M from the National Institute of Dental and Craniofacial Research (NIH) for oral mucositis drug development.
October 29, 2021
GlycoMira receives $2M from the National Institute of Allergy and Infectious Diseases (NIH) for chronic rhinosinusitis drug development
June 24, 2021
Other News
GlycoMira participated in the pitch competition at the 2022 Wilson Sonsini Entrepreneur & Investor Summit sponsored by BioUtah and BioHive on March 9th, 2022.
Visit with Dr. Won Yong Lee at the upcoming American Association for Cancer Research Annual Meeting in New Orleans (April 8-13th). He will be presenting GlycoMira’s preclinical findings in head and neck cancer models.
Visit with Drs. Abby Pulsipher and Glenn Prestwich at the upcoming Gordon Research Conference on Proteoglycans in Andover (July 10-15th). Dr. Pulsipher will be presenting preclinical results in chronic rhinosinusitis and cystic fibrosis models.
© GlycoMira Therapeutics, Inc.
All rights reserved.